In the quarterly update to the End-Stage Renal Disease (ESRD) Prospective Payment System (PPS), a new HCPCS Level II code is being added for anemia management with an effective date of July 1, 2019. J1444 Injection, ferric pyrophosphate citrate powder, 0.1 mg of iron This code is subject to Medicare Part B consolidated billing and, […]
The post Reporting J1444 under ESRD PPS appeared first on AAPC Knowledge Center.